Liberty Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History

Liberty Wealth Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $55,227 - $69,716	-312 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $11.7 Million - $13.8 Million	-62,597 Reduced 99.5%	312 $63,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $11.7 Million - $13.8 Million	62,584 Added 19256.62%	62,909 $312,000
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $207 - $276	1 Added 0.31%	325 $75,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $3,067 - $3,637	12 Added 3.85%	324 $88,000
Q2 2020 Aug 04, 2020	SELL	$225.48 - $295.8 $23,675 - $31,059	-105 Reduced 25.18%	312 $91,000
Q1 2020 Apr 27, 2020	BUY	$199.77 - $247.81 $9,788 - $12,142	49 Added 13.32%	417 $99,000
Q4 2019 Feb 05, 2020	SELL	$166.71 - $223.91 $3,167 - $4,254	-19 Reduced 4.91%	368 $81,000
Q2 2019 Jul 30, 2019	BUY	$164.61 - $190.37 $49,053 - $56,730	298 Added 334.83%	387 $71,000
Q4 2018 Mar 26, 2019	BUY	$151.91 - $192.21 $13,519 - $17,106	89 New	89 $14,000

1,726

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.